Literature DB >> 9157974

Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.

M R Emmert-Buck1, I A Lubensky, Q Dong, P Manickam, S C Guru, M B Kester, S E Olufemi, S Agarwal, A L Burns, A M Spiegel, F S Collins, S J Marx, Z Zhuang, L A Liotta, S C Chandrasekharappa, L V Debelenko.   

Abstract

Multiple endocrine neoplasia type I (MEN1) is an inherited syndrome that results in parathyroid, anterior pituitary, and pancreatic and duodenal endocrine tumors as well as foregut carcinoids in affected patients. The gene responsible for the disease has been linked to chromosome 11q13. We analyzed loss of heterozygosity (LOH) in 188 tumors from 81 patients in an attempt to further define the location of the MEN1 gene. Both tumors from MEN1 patients and corresponding sporadic tumors were analyzed. Tumor types included parathyroid, gastrinoma, pancreatic endocrine, pituitary, and lung carcinoid. Six tumors (three MEN1 and three sporadic tumors) were identified that provided important LOH boundaries. Four tumors (two parathyroid tumors, one gastrinoma, and one lung carcinoid tumor) showed allelic loss that placed the MEN1 gene distal to marker PYGM. Two tumors (one gastrinoma and one parathyroid tumor) showed an LOH boundary that placed the gene proximal to D11S449, one of which further moved the telomeric boundary to D11S4936. Taken together, the present data suggest that the MEN1 gene lies between PYGM and D11S4936, a region of approximately 300 kb on chromosome 11q13.

Entities:  

Mesh:

Year:  1997        PMID: 9157974

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Molecular profiling of clinical tissues specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prang; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

Review 2.  Molecular profiling of clinical tissue specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prange; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.

Authors:  Xiao-Jie Ding; Min-Xia Liu; Lei Ao; Yi-Rong Liang; Yi Cao
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

4.  A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.

Authors:  S C Guru; S K Agarwal; P Manickam; S E Olufemi; J S Crabtree; J M Weisemann; M B Kester; Y S Kim; Y Wang; M R Emmert-Buck; L A Liotta; A M Spiegel; M S Boguski; B A Roe; F S Collins; S J Marx; L Burns; S C Chandrasekharappa
Journal:  Genome Res       Date:  1997-07       Impact factor: 9.043

5.  Menin immunoreactivity in secretory granules of human pancreatic islet cells.

Authors:  Larisa V Debelenko; Sunita Agarwal; Qiang Du; Wusheng Yan; Heidi S Erickson; Mones Abu-Asab; Mark A Raffeld; Steven K Libutti; Stephen J Marx; Michael R Emmert-Buck
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 Nov-Dec

Review 6.  The MEN1 gene and associated diseases: an update.

Authors:  T Tsukada; K Yamaguchi; T Kameya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

7.  Novel DNA copy number losses in chromosome 12q12--q13 in adenoid cystic carcinoma.

Authors:  W El-Rifai; S Rutherford; S Knuutila; H F Frierson; C A Moskaluk
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

8.  Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how.

Authors:  Alberto Falchetti
Journal:  F1000 Med Rep       Date:  2010-02-24

9.  The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis.

Authors:  F Marini; S Carbonell Sala; A Falchetti; D Caramelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 10.  Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.

Authors:  A K Walch; H F Zitzelsberger; M M Aubele; A E Mattis; M Bauchinger; S Candidus; H W Präuer; M Werner; H Höfler
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.